Summit Therapeutics Inc (SMMT) Implied Volatility Current

Tracking SMMT implied volatility helps you identify when options premiums on Summit Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Summit Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when SMMT IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Summit Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For SMMT, tracking metrics like SMMT IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on SMMT signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also offers SMT-738, for combating multidrug resistant infections primarily carbapenem-resistant Enterobacteriaceae infections; and DDS-04 series for the potential treatment of infections caused by the Enterobacteriaceae.

The company was founded in 2003 and is based in Cambridge, Massachusetts.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where SMMT implied volatility sits today versus where it has been. Our scanner ranks Summit Therapeutics Inc implied volatility against its historical range, surfaces extremes in SMMT IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Summit Therapeutics Inc IV is rich or cheap — measure it, then act on it.